About TerraVia
TerraVia is a company based in San Francisco (United States) founded in 2003 was acquired by Corbion in September 2017. TerraVia has raised $60 million across 6 funding rounds from investors including Morgan Stanley, Corbion and Unilever. TerraVia operates in a competitive market with competitors including Enzymotec, Microphyt, Advanced Enzyme Technologies, Fermentalg and Simris Alg, among others.
- Headquarter San Francisco, United States
- Stage Public
-
Sectors
HealthcareAgriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$60 M (USD)
in 6 rounds
-
Latest Funding Round
Not available
-
Investors
Morgan Stanley
& 17 more
-
Employee Count
Not available
-
Acquired by
Corbion
(Sep 29, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of TerraVia
TerraVia has successfully raised a total of $60M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in TerraVia
TerraVia has secured backing from 18 investors, including venture fund and institutional investors. Prominent investors backing the company include Morgan Stanley, Corbion and Unilever.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-sector company acquisitions are managed by VMG Partners.
|
Locked | Locked | Locked | |
|
Offline focused VC firm funding companies in the US
|
Locked | Locked | Locked | |
|
Venture capital fund focused on multiple sectors
|
Locked | Locked | Locked |
Investor details for TerraVia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TerraVia
Investment portfolio details for TerraVia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TerraVia
Detailed financials for TerraVia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Terravia Comparisons
Peer comparison for TerraVia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TerraVia
TerraVia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzymotec, Microphyt, Advanced Enzyme Technologies, Fermentalg and Simris Alg, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Bio-functional lipid ingredients are developed for nutritional and pharmaceutical uses.
|
|
| Locked | Locked | Locked |
Microalgae cultivation technology is developed and supplied.
|
|
| Locked | Locked | Locked |
Enzymes are manufactured for nutrition, food, feed, and textile industries.
|
|
| Locked | Locked | Locked |
Microalgae are processed via fermentors to yield biomass feedstock.
|
|
| Locked | Locked | Locked |
Algae are cultivated, harvested, and processed into oils and products.
|
Detailed competitors of TerraVia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Terravia
Complete news archive for TerraVia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TerraVia
TerraVia was founded in 2003 and raised its 1st funding round 4 years after it was founded.
TerraVia is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
TerraVia is a funded company, having raised a total of $60M across 6 funding rounds to date.
TerraVia was founded in 2003 in San Francisco, United States, and operates in the biotechnology and food ingredients sector. Algae-derived specialty ingredients are produced through an industrial fermentation process that converts natural sugars into oils, proteins, fats, fibers, and micronutrients. These components are supplied for nutritional food applications, with production methods avoiding genetically engineered algae. Operations emphasize sustainable practices in ingredient development and distribution.
TerraVia's top competitors include Fermentalg, Microphyt and Advanced Enzyme Technologies.
TerraVia has 18 investors. Key investors include Morgan Stanley, Corbion, Unilever, Lightspeed Venture Partners, and Bunge.